Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
以安慰剂为对照,评价颈泰胶囊治疗神经根型颈椎病(气滞血瘀证)有效性和安全性随机、双盲Ⅲ期临床试验
[Translation] A randomized, double-blind phase III clinical trial to evaluate the efficacy and safety of Jingtai capsule in the treatment of cervical spondylotic radiculopathy (Qi stagnation and blood stasis syndrome) with placebo as control
以安慰剂为对照,评价颈泰胶囊治疗神经根型颈椎病(气滞血瘀证)有效性和安全性的分层区组随机、双盲单模拟、多中心Ⅲ期临床试验
[Translation] A stratified block randomized, double-blind, single-dummy, multicenter phase III clinical trial to evaluate the efficacy and safety of Jingtai capsule in the treatment of cervical spondylotic radiculopathy (Qi stagnation and blood stasis syndrome) with placebo as control
100 Clinical Results associated with Shaanxi Kemai Pharmaceutical Development Co., Ltd.
0 Patents (Medical) associated with Shaanxi Kemai Pharmaceutical Development Co., Ltd.
100 Deals associated with Shaanxi Kemai Pharmaceutical Development Co., Ltd.
100 Translational Medicine associated with Shaanxi Kemai Pharmaceutical Development Co., Ltd.